secwatch.observer — SEC 8-K summary
======================================

Issuer:     Incannex Healthcare Inc. (IXHL)
CIK:        0001873875
Form:       8-K
Filed at:   2025-04-25T23:59:59+00:00
Accession:  0001213900-25-035636
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 8.01, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Incannex receives Nasdaq bid price deficiency notice; cure period until Oct 20, 2025
--------------------------------------------------------------------------------

- Closing bid price of IXHL common stock below $1.00 for 30 consecutive trading days.
- Nasdaq granted 180-day compliance period ending October 20, 2025.
- If not compliant, Company may transfer to Nasdaq Capital Market for additional 180-day cure.
- Lead asset IHL-42X (obstructive sleep apnea) Phase 2 top-line data expected before end of H1 2025.
- Company evaluating options including reverse stock split to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873875/000121390025035636/0001213900-25-035636-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873875/000121390025035636/ea0239610-8k_incannex.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-035636

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer